ARTICLE | Clinical News
Viscogel: Phase I/II data
April 1, 2013 7:00 AM UTC
A single-blind, Swedish Phase I/II trial in about 130 healthy volunteers showed that single ascending-doses of ViscoGel as an adjuvant to the ActHIB Hib vaccine were well tolerated and met the primar...